Regulation & Compliance

New military rules for destroying toxic PFAS create a critical opening for companies like Revive Environmental and their high-tech, permanent solutions.

Coconut's new platform promises to break down banking silos for a seamless customer experience, but can it overcome deep-rooted operational and compliance hurdles?

Analyst firm KuppingerCole names 1Kosmos a leader for its innovative platform that unifies identity proofing and device trust to combat modern cyber threats.

The world's top Bitcoin mining operator is launching a Zcash pool, aiming to merge institutional compliance with cryptocurrency's privacy frontier.

HearMe and Sleep.ai are betting that the key to your mental health is in your sleep, launching a new integration that goes beyond simple relaxation.

A new report reveals a startling disconnect: while 89% of execs feel AI boosts productivity, the time spent validating AI's work leads to net time losses.

New AI-powered screening solution aims to slash false positives and help smaller financial institutions combat complex financial crime and reputational risk.

A new report says 10 advanced reactors could add $1T to the U.S. economy, but past project failures and major workforce hurdles cast a long shadow.

EarnIn’s Live Pay surpasses one million transactions, but a complex web of fees, competition, and regulatory scrutiny challenges the future of instant income.

Seedtag launches Liz Agent, a conversational AI using Neuro-Contextual data to automate and enhance media planning in a privacy-first advertising world.

As the oral stimulant pouch market booms, Doseology Sciences Inc. uplists to the OTCQB to capture U.S. investors and a new wave of consumers.

A new survey reveals small business owners are holding back on investment due to government spending and policy uncertainty, despite recent tax incentives.

In the wake of global infant formula recalls, a new diagnostic tool offers rapid detection of the dangerous cereulide toxin to protect vulnerable patients.

A landmark CHF 83.5M deal brings corticorelin, a promising steroid-sparing therapy for brain cancer patients, to Japan, offering a new frontier in care.

As a $150M expansion nears completion, Louisiana's largest casino bets on a 20-year veteran to steer its financial future and tribal economic goals.

After a 39% stock crash, Lakeland Industries' former CFO is sued over allegedly misleading investors about the company's deteriorating financial health.

Dallas Nephrology Associates earns its second Burl Osborne Award, a testament to its sustained, innovative commitment to fighting kidney disease in Texas.

As evidence for psychedelic therapy mounts, a key advocacy group brings its case to the UN, challenging decades of prohibitive international drug policy.

Las Vegas conference to address agentic AI risks, future-proofing against cyber threats, and the urgent need for upskilling in a complex digital world.

A federal ban meant to protect youth has pushed nicotine pouches into an illicit market, raising questions about the policy's effectiveness and its impact on retailers.